Ane Beatriz Eguzkitza

The prevalence of inflammatory upper airways diseases effects an estimated 20% of the worldwide population. These pathologies damage the life quality of approximate 1000 millions of people suffering with these dieseases and implies a huge economic cost.

Existing treatments do not offer enough efficacy to successfully fight these diseases. The...